
Keywords: ضد سل; 1,3,4-Oxadiazol,4-(5-pentadecyl-1,3,4-oxadiazol-2-yl)pyridine; Lipophilic; Mycobacterium tuberculosis; MDR; Liposomes; anti-TB; anti-Tuberculosis; CFU; Colony-forming units; Chol; cholesterol; FDA; U.S. Federal Drug Administration; H&E; Hematoxylin and Eo